Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to examine the efficacy of topiramate in combination
with olanzapine for the prevention of weight gain in youth with bipolar disorder. The
secondary objective is to examine the tolerability of topiramate in combination with
olanzapine for the prevention of weight gain in youth with bipolar disorder.